Showing 1811-1820 of 2976 results for "".
- Allergan Aesthetics Launches New SkinMedica HA5 Hydra Collagen Replenish + Restore Hydratorhttps://modernaesthetics.com/news/allergan-aesthetics-launches-new-skinmedica-ha5-hydra-collagen-replenish-restore-hydrator/2473663/Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica HA5 Hydra Collagen Replenish + Restore Hydrator. The new product is specifically designed to deliver unparalleled hydration, visible plumpness, and radiance to facial skin. The new SkinMedic
- Fake Doctor Charged After Injuring Woman During Cosmetic Procedure, LA Prosecutors Sayhttps://modernaesthetics.com/news/fake-doctor-charged-after-injuring-woman-during-cosmetic-procedure-la-prosecutors-say/2473661/Cristian Perez Latorre faces assault and battery charges after allegedly impersonating a doctor and performing a cosmetic surgery that led to “great bodily injury in Los Angeles in 2021, the Los Angeles County District Attorney’s Office announced last week. Prosecutors
- Botox Pioneer Dr. James Alastair Carruthers Dies at Age 79https://modernaesthetics.com/news/botox-pioneer-dr-james-alastair-carruther-dies-at-age-79/2473658/Dr. James Alastair Carruthers, a pioneer physician in the discovery and evolution of botulinum toxin A, passed away on Monday at age 79. CarruthersCosmetic po
- Novaestiq’s Partner Croma-Pharma Submits Final Application for Hyaluronic Acid Dermal Fillerhttps://modernaesthetics.com/news/novaestiqs-partner-croma-pharma-submits-final-application-for-hyaluronic-acid-dermal-filler/2473657/Novaestiq Corp., an aesthetic company that focuses on delivering intelligent and innovative skin solutions to practices and patients, announced its partner Croma-Pharma GmbH finalized the submission of its premarket approval to the US Food and Drug Administration (FDA) for the saypha MagIQ hyalur
- Pre-Clinical Study for Regenerative Commercial-Sized Breast Implants Announcedhttps://modernaesthetics.com/news/pre-clinical-study-for-regenerative-commercial-sized-breast-implants-announced/2473655/The advancement of regenerative medicine continues to grow at a rapid pace. CollPlant Biotechnologies and Stratasys Ltd. announced the initiation of a pre-clinical study with 200cc commercial-sized regenerative implants printed on Stratasys Origin 3D printer. The collaboration is
- Crown Laboratories, Revance Announce Entry Into Merger Agreementhttps://modernaesthetics.com/news/crown-laboratories-revance-announce-entry-into-merger-agreement/2473649/Crown Laboratories, Inc., a privately held, global innovative leader in the skincare industry, and Revance Therapeutics, Inc., a biotechnology company aimed at setting the new standard in healthcare with innovative aesthetic and therapeutic offerings, announced a merger agreement pursuant to whic
- L’Oréal Eyes Aesthetics Market with Acquisition of Minority Stake in Galdermahttps://modernaesthetics.com/news/loreal-eyes-aesthetics-market-with-acquisition-of-galderma/2473646/Major beauty brand L’Oréal announced the acquisition of a 10% stake in Galderma, a Swiss pharmaceutical company. The two companies have agreed to work towards a strategic scientific partnership that will leverage the undisputed expertise of both companies, according to a press releas
- Signature Facial Experience from Luxury Australian Beauty Brand Now Available in NYChttps://modernaesthetics.com/news/signature-facial-experience-from-luxury-australian-beauty-brand-now-available-in-nyc/2473643/A popular signature facial experience from the Australian luxury beauty brand RATIONALE is now available in New York City. The company launched the RATIONALE Residency at the Equinox Hotel, and private in-home appointments by request, on August 1. Rationale is known for its luxuri
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- Allergen Aesthetics Brings Back JUVÉDERM® Dayhttps://modernaesthetics.com/news/allergen-aesthetics-brings-back-juvederm-day/2473639/Allergan Aesthetics announced the return of JUVÉDERM® Day on Wednesday, August 21. The event, held for the first time last year, features limited-time offers, savings, and exclusive deals through Allē, the Allergan Aesthetics loyalty rewards program.